Want to join the conversation?
Belgian pharmaceutical research company $GLPG and $GILD entered into a partnership for the development and commercialization of the JAK1-selective inhibitor filgotinib for inflammatory disease indications. An upfront payment of $725MM will be given to $GLPG that comprises of a license fee of $300MM and a $425MM equity investment in $GLPG.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?